Archive for December, 2015
Editor’s Note: The following paper is part of CRE’s ongoing survey and analysis of regulatory review techniques and processes around the world. Dr. Feil deserves special recognition for his keen understanding of the development of regulatory review in the US. For more information about Brazilian regulation, see CRE Brazil. The complete paper, “Improving Regulatory Impact Analysis at the Brazilian Electricity Regulatory Agency,” is available here. Below is a brief extract.
From: George Washington University | The Minerva Program
By ALEX SANDRO FEIL
by Jeff Rosen
This month the House of Representatives passed two resolutions under the Congressional Review Act (5 USC 801, et seq .) that disapproved of EPA’s recent rules for greenhouse gases from new and existing power plants. S.J. Resolutions 23 and 24. These two resolutions had already passed the Senate on November 17, 2015. The vote in the Senate was 52-46, and in the House was 235-188. These resolutions of disapproval will next go to the President, who has previously threatened to veto them. They are only the third and fourth times that both houses of Congress have ever sent a resolution of disapproval of agency rules to the President.
Inaccurate and misleading data being disseminated in federal databases threatens public health and fiscal integrity. CMS’s National Provider Identifier database and GSA’s Federal Procurement Data System-Next Generation are only two examples of federal databases that are disseminating data that don’t meet federal data quality requirements. The Data Quality Act provides a process for correcting data in federal databases. For an example of using the DQA to address technical problems with CMS’s star quality rating systems, see CRE’s letter to CMS here. Also see CMS’s detailed response to CRE’s letter here.
From: Health Affairs
Valuing Life: Humanizing The Regulatory State By Cass R. Sunstein Chicago (IL): University of Chicago Press, 2014 240 pp., $25.00
In the well-written book Valuing Life, Cass Sunstein, currently the Robert Walmsley University Professor at Harvard University, explains the workings of a relatively small and obscure but key agency in the Office of Management and Budget called the Office of Information and Regulatory Affairs (OIRA). Sunstein’s insights into the workings of OIRA and the many conceptual and empirical challenges the office faces come from his experience as the administrator of OIRA from 2009 to 2012. While most people—including most of my colleagues in the health policy community—have probably never heard of OIRA, I have been very aware of its activities and responsibilities since my time running Medicare and Medicaid as the administrator of the Health Care Financing Administration (HCFA, now called the Centers for Medicare and Medicaid Services), given the HCFA’s role as a regulatory agency.
by Daniel R. Pérez, Policy Analyst
As Presidential administrations begin to wind down during their “lame duck” period, the executive’s decrease in political influence in congress has historically been accompanied by a significant increase in the amount of regulations published by executive regulatory agencies, particularly during the final three months between Election Day and Inauguration Day. This flurry of last-minute regulatory activity, identified as early as the Carter administration’s transition to Reagan, is known as the Midnight period. Midnight rules are so named because they are the result of an executive fully exercising its power to influence policy through regulation in a rush to beat the “stroke of Midnight” on inauguration day, which removes its political power—like Cinderella’s magic running out as she leaves the ball.
Editor’s Note: From time to time CRE examines the role of centralized regulatory review in state governments.
From: The Washington Post
By Josh Hicks
A commission examining ways to improve Maryland’s regulatory environment called Tuesday for the largest restructuring of the state’s government since former Gov. Marvin Mandel overhauled the executive branch 45 years ago.
The recommendation was part of the first report from a regulatory-review panel Gov. Larry Hogan (R) appointed this year to help make the state more business-friendly.
by Brandi Lupo. Original source: www.regblog.org
Official articulations of executive agency positions require preclearance by the Office of Management and Budget (OMB) in the White House. Written official statements on pending bills, draft bills that an agency wishes to present to Congress, and other legislative activities all require preclearance. At the same time, White House preclearance is not required for legislative language that agencies offer to congressional committees as a “drafting service” provided that the agency makes clear that the administration or agency is not bound to the position espoused in the drafted language.
From: The Commentator
Author: Adam Kramer
The Syms School of Business community was fortunate to hear from Senator Joseph Lieberman on Tuesday November 17th, where the former Senator from Connecticut and current occupant of the Lieberman Chair of Public Policy and Public Service at Yeshiva University spoke on the topic of “Why American Business Needs a Strong Federal Government, But Not Too Strong.”